Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Early Phase 1
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07461155Early Phase 1Not Yet Recruiting

Stingless Bee Honey Mouth Rinse on Gingivitis

Role: collaborator

NCT05444179Not ApplicableCompleted

Nutrition and Physical Activity Intervention on Psychosocial Well-Being of Postpartum Mothers

Role: collaborator

NCT06223243Not ApplicableCompleted

The Effect of Stingless Bee Honey Mouthrinse on Dental Plaque Accumulation

Role: lead

NCT04410159Phase 2Completed

Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients

Role: lead

All 4 trials loaded